A. McCreary
发表
J. V. van Maarseveen,
Adri van den Hoogenband,
A. McCreary,
2006,
Bioorganic & medicinal chemistry letters.
J. Mcblane,
A. McCreary,
H. Spooner,
1996,
Polish journal of pharmacology.
M. Filip,
E. Przegaliński,
M. Zaniewska,
2008,
Synapse.
A. McCreary,
R. Feenstra,
Caitlin A. Jones,
2012
.
C. Kruse,
W. Wadman,
A. McCreary,
2006,
Current neuropharmacology.
M. Filip,
E. Przegaliński,
M. Zaniewska,
2008,
Pharmacological reports : PR.
P. Jenner,
B. Zeng,
Maria Papathanou,
2014,
European journal of pharmacology.
P. Jenner,
S. Rose,
L. Johnston,
2010,
Movement disorders : official journal of the Movement Disorder Society.
A. McCreary,
S. Handley,
2000,
Journal of psychopharmacology.
Stephen P. H. Alexander,
C. Marsden,
A. McCreary,
2006,
Pharmacology Biochemistry and Behavior.
P. Jenner,
S. Rose,
L. Johnston,
2010,
European Neuropsychopharmacology.
K. Freeman,
W. Woolverton,
D. Heal,
2012,
Drug and alcohol dependence.
J. Venhorst,
T. Vries,
A. McCreary,
2013,
Behavioural Brain Research.
M. Filip,
K. Cunningham,
A. McCreary,
2003,
Behavioral neuroscience.
W. Dimpfel,
C. Parsons,
C. Jatzke,
2015,
Journal of Neural Transmission.
M. Filip,
E. Przegaliński,
M. Zaniewska,
2006,
European journal of pharmacology.
A. McCreary,
Caitlin A. Jones,
2010,
Current pharmaceutical design.
U. Spampinato,
M. Filip,
E. Przegaliński,
2013,
Experimental Brain Research.
J. Brotchie,
S. Fox,
R. D. de Bie,
2008,
Movement disorders : official journal of the Movement Disorder Society.
C. Kruse,
W. Wadman,
Benny Perlstein,
2004,
European journal of pharmacology.
W. Wadman,
A. McCreary,
T. Werkman,
2006,
CNS & neurological disorders drug targets.
B. Roth,
E. Lambe,
M. Camilleri,
2020,
Pharmacological Reviews.
J. Lange,
C. Kruse,
A. McCreary,
2005,
Journal of medicinal chemistry.
J. Lange,
C. Kruse,
E. Ronken,
2004,
Journal of medicinal chemistry.
K. Cunningham,
A. McCreary,
1999,
Neuropsychopharmacology.
U. Spampinato,
M. Filip,
E. Przegaliński,
2012,
Brain Research.
M. Papp,
M. Filip,
P. Adamczyk,
2012,
Brain Research.
M. Filip,
E. Przegaliński,
M. Kruk,
2012,
Pharmacological reports : PR.
A. McCreary,
S. Handley,
Andrew C. McCreary,
1999,
European journal of pharmacology.
J. Glennon,
H. Meltzer,
C. Kruse,
2007,
Neuropsychopharmacology.
J. Reinders,
A. McCreary,
W. Goutier,
2010,
Journal of Neuroscience Methods.
C. Kruse,
W. Wadman,
A. McCreary,
2011,
Synapse.
A. Newman-Tancredi,
M. Varney,
A. McCreary,
2018,
Neurochemical Research.
A. Newman-Tancredi,
M. Varney,
A. McCreary,
2016,
Neuropharmacology.
B. Jacobs,
C. Fornal,
S. Veasey,
1996,
The Journal of pharmacology and experimental therapeutics.
S. Fox,
V. Sgambato-Faure,
P. Huot,
2017,
ACS chemical neuroscience.
M. Filip,
C. Müller,
A. McCreary,
2015,
International review of neurobiology.
P. Jenner,
M. Iravani,
A. McCreary,
2012,
Parkinsonism & related disorders.
K. Cunningham,
A. McCreary,
M. G. Bankson,
1999,
The Journal of pharmacology and experimental therapeutics.
K. Marquis,
S. Grauer,
J. Brennan,
2009,
Bioorganic & medicinal chemistry letters.
R. Depoortère,
A. Newman-Tancredi,
M. Kleven,
2015,
Experimental Neurology.
P. Jenner,
D. Scheller,
A. McCreary,
2011,
Journal of Neural Transmission.
A. McCreary,
N. Bruin,
B. M. Kloeze,
2011,
Neuropharmacology.
M. Filip,
E. Przegaliński,
M. Zaniewska,
2006,
Pharmacological reports : PR.
M. Filip,
P. Bieńkowski,
P. Adamczyk,
2009,
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
A. McCreary,
Caitlin A. Jones,
2008,
Neuropharmacology.
Novel 3,4-diarylpyrazolines as potent cannabinoid CB1 receptor antagonists with lower lipophilicity.
J. Lange,
C. Kruse,
A. McCreary,
2005,
Bioorganic & medicinal chemistry letters.
M. Filip,
P. Adamczyk,
E. Przegaliński,
2008,
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
M. Papp,
M. Filip,
P. Bieńkowski,
2010,
Pharmacological reports : PR.
E. Ronken,
J. Reinders,
M. Hesselink,
2006,
Synapse.
A. McCreary,
2017
.
A. Newman-Tancredi,
M. Cenci,
M. Varney,
2015,
Neuropharmacology.
M. Filip,
E. Przegaliński,
M. Kruk,
2011,
Pharmacological reports : PR.
M. Filip,
K. Wydra,
M. Zaniewska,
2010,
Synapse.
M. Filip,
M. Zaniewska,
A. McCreary,
2009,
Synapse.
A. McCreary,
W. Goutier,
Margreet Kloeze,
2016,
Addiction biology.
A. McCreary,
W. Goutier,
Margreet Kloeze,
2015,
Addiction biology.
M. Filip,
N. Alenina,
Wei Chen,
2015,
Journal of neurochemistry.
J. Lowry,
A. McCreary,
W. Goutier,
2015,
European Neuropsychopharmacology.
K. Szumlinski,
A. McCreary,
K. D. Lominac,
2010,
Psychopharmacology.
K. Marquis,
S. Grauer,
J. Brennan,
2010,
Journal of Pharmacology and Experimental Therapeutics.
B. Jacobs,
C. Fornal,
C. Dourish,
1994
.
Effects of serotonin (5-HT)2 receptor ligands on depression-like behavior during nicotine withdrawal
M. Filip,
K. Wydra,
M. Zaniewska,
2010,
Neuropharmacology.
P. Jenner,
S. Rose,
M. Jackson,
2010,
Experimental Neurology.
C. Kruse,
W. Wadman,
A. McCreary,
2004,
Neuropharmacology.
A. Newman-Tancredi,
A. McCreary,
2015,
Current pharmaceutical design.
Kazuhiko Nakamura,
A. McCreary,
C. Ashby,
2006,
Synapse.
J. Lowry,
A. McCreary,
W. Goutier,
2016,
Neurochemical Research.
K. Rasmussen,
E. Shanks,
A. McCreary,
2004,
Neuroscience Letters.
E. Steed,
A. McCreary,
Caitlin A. Jones,
2011,
Behavioural Brain Research.
P. Jenner,
Maria Papathanou,
S. Rose,
2011,
The European journal of neuroscience.
M. Filip,
E. Przegaliński,
M. Zaniewska,
2007,
European journal of pharmacology.
C. Marsden,
A. McCreary,
1993,
Neuropharmacology.
C. Kruse,
M. Hesselink,
A. McCreary,
2003,
Bioorganic & medicinal chemistry letters.
S. Stahl,
A. Brickman,
R. Perlis,
2010
.
C. Bétry,
N. Haddjeri,
L. Lambás-señas,
2011,
Synapse.
A. McCreary,
S. Handley,
1995,
Journal of psychopharmacology.
Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats
P. Jenner,
Maria Papathanou,
S. Rose,
2013,
Movement disorders : official journal of the Movement Disorder Society.
Stephen P. H. Alexander,
C. Marsden,
A. McCreary,
2006,
Pharmacology, Biochemistry and Behavior.
C. Nocjar,
E. Pehek,
Mary V. Burke,
2014,
Journal of neurochemistry.
Novel 3,4‐Diarylpyrazolines as Potent Cannabinoid CB1 Receptor Antagonists with Lower Lipophilicity.
J. Lange,
C. Kruse,
A. McCreary,
2006
.
N. Zahniser,
T. Hanania,
A. McCreary,
2004,
European journal of pharmacology.
C. Kruse,
A. Herremans,
M. Hesselink,
2005
.
H. Haughey,
N. Zahniser,
T. Hanania,
2002,
European journal of pharmacology.
U. Spampinato,
M. Filip,
E. Przegaliński,
2013,
Experimental Brain Research.
M. Filip,
M. Zaniewska,
A. McCreary,
2009,
Synapse.
M. Filip,
A. Faron-Górecka,
K. Wydra,
2015,
Pharmacological reports : PR.
A. McCreary,
W. Goutier,
Margreet Kloeze,
2016,
Addiction biology.
K. Szumlinski,
A. McCreary,
K. D. Lominac,
2010,
Psychopharmacology.
S. Dursun,
H. Rickards,
A. McCreary,
1993,
British Journal of Psychiatry.
P. Jenner,
S. Rose,
L. Johnston,
2010,
Movement disorders : official journal of the Movement Disorder Society.
C. Bétry,
N. Haddjeri,
L. Lambás-señas,
2011,
Synapse.
C. Kruse,
T. Tuinstra,
J. A. Heyden,
2001,
European Neuropsychopharmacology.
M. Filip,
E. Przegaliński,
M. Kruk,
2011,
Pharmacological reports : PR.
P. Jenner,
Maria Papathanou,
S. Rose,
2011,
The European journal of neuroscience.